BridgeBio Oncology Therapeutics Inc. (BBOT) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for BridgeBio Oncology Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
BridgeBio Oncology Therapeutics Inc. (BBOT) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $216M. It trades at $2.80, up 4.09% today. Its overall quality score is 44 out of 100, ranked against the whole US market. 8 analysts' average target of $19.63 implies +601.1% from today's price. Kronos AI's 30-day forecast is +157.4% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $19.63 |
| Low – high | $13.00 – $25.00 |
| Analysts | 8 |
| Upside to average | +601.1% |
Kronos AI 30-day forecast
| Expected close | $6.92 (+157.4%) |
| Likely range | +141.0% … +172.6% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 38 |
| Solvency | 60 |
| Growth | 35 |
| Overall | 44 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator